Role of vasoactive intestinal polypeptide in burn-induced oedema formation

Burns

Volumn 26, Issue 5, 2000, Pages 443-448

  Lindblom, L ^a,b   Cassuto, J ^a,b   Yregard L ^a,b   Tarnow, P ^b   Rantfors J ^a,b   Lowhagen Henden P ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Burns; Oedema; Vasoactive intestinal peptide

Indexed keywords

EVANS BLUE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CAPILLARY PERMEABILITY; CONTROLLED STUDY; EDEMA; EXTRAVASATION; HEART RATE; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; SKIN BLOOD FLOW;

ANIMALS; BLOOD PRESSURE; BURNS; CAPILLARY PERMEABILITY; COLORING AGENTS; EDEMA; EVANS BLUE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HEART RATE; HYPOTENSION; IMMUNE SERA; INFLAMMATION MEDIATORS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SKIN DISEASES; SODIUM CHLORIDE; SPECTROPHOTOMETRY; VASOACTIVE INTESTINAL PEPTIDE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0034256928     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(99)00177-1     Document Type: Article

References (37)

1. Arturson G. Possible involvement of arachidonic acid metabolites in thermal injury. Dolecek R., Brizio-Molteni L., Molteni A., Traber D. Endocrinology of thermal injury: pathophysiologic mechanisms and clinical interpretation. 1990;238-252 Lea & Febiger, Philadelphia.
2. Tarnow P., Cassuto J., Jönsson A., Bennett A., Tavares I.A. Effects of D-myo-inositol-1,2,6-trisphosphate on eicosanoid formation in burned skin. J. Surg. Res. 62:1996;1-4.
3. Jönsson A, Cassuto J, Tarnow P, Sinclair R, Bennett A, Tavares IA. Effects of amide local anaesthetics on eicosanoid formation in burned skin. Acta Anaesthesiol Scand 1999;43:618-22.
4. Rocha e Silva M., Rosenthal S.R. Release of pharmacologically active substances from the rat skin in vitro following thermal injury. J. Pharmacol. Exp. Therap. 132:1961;110-116.
5. Starr M.S., West G.B. Bradykinin and oedema formation in heated paws of rats. Br. J. Pharmacol. 31:1967;178-187.
6. Wirth KJ, Alpermann HG, Satoh R, Inazu M. The bradykinin antagonist Hoe 140 inhibits carrageenan- and thermically induced paw oedema in rats. Agents Actions 1992;38(suppl.):428-31.
7. Arturson G. The plasma kinins in thermal injury. Scand. J. Clin. Lab. Invest. 24:1969;153-162.
8. Saria A. Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury. Br. J. Pharmacol. 82:1984;217-222.
9. Ferrara J.J., Dyess D.L., Luterman A., Peterson R.D., Curreri P.W. In vitro effects of complement inactivation upon burn-associated cell-mediated immunosuppression. Am. Surg. 56:1990;571-574.
10. Warren J.B., Wilson A.J., Lo R.K., Coughlan M.L. Opposing roles of cyclic AMP in the vascular control of edema formation. Faseb. J. 7:1993;1394-1400.
11. Williams T.J. Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin. Br. J. Pharmacol. 77:1982;505-509.
12. Dobbins D.E., Soika C.Y., Premen A.J., Dabney J.M. Forelimb vascular pressures, skin lymph flow and lymph protein concentration as affected by vasoactive intestinal polypeptide and bombesin. Microcirc. Endothelium Lymphatics. 1:1984;691-703.
13. Khalil Z., Anrews P.V., Helme R.D. VIP modulates substance P-induced plasma extravasation in vivo. Eur. J. Pharmacol. 151:1988;281-287.
14. Hartschuh W., Reinecke M., et al. VIP-immunoreactivity in the skin of various mammals: immunohistochemical, radioimmunological and experimental evidence for a dual localisation in cutaneous nerves and merkel cells. Peptide. 5:1984;239-245.
15. Jönsson A., Brofeldt B.T., Nellgård P., Tarnow P., Cassuto J. Local anesthetics improve dermal perfusion after burn injury. J. Burn Care Rehabil. 19:1998;50-56.
16. Cassuto J., Nellgård P., Stage L., Jönsson A. Amide local anesthetics reduce albumin extravasation in burn injuries. Anesthesiology. 72:1990;302-307.
17. Tarnow P., Jönsson A., Lindblom L., Gustafsson T., Cassuto J. Topical D-myo-inositol-1,2,6-trisphosphate and hexylbetaine treatment reduces albumin extravasation in experimental rat skin burn injury. Burns. 24:1998;460-463.
18. Goldie P., Hellstrom S., Idahl L.A. Middle ear effusion induced by various inflammatory mediators and neuropeptides. An experimental study in the rat. Acta Otolaryngol. 108:1989;246-252.
19. Cardell L.O., Stjarne P., Waggstaff S.J., Augusti C., Nedel J.A. PACAP-induced plasma extravasation in rat skin. Regul. Pept. 71:1997;67-71.
20. Olesen S.P., Crone C. Substances that rapidly augment ionic conductance of endothelium in cerebral venules. Acta Physiol. Scand. 127:1986;233-241.
21. Asztely G., Havel G., Ekstrom J. Vascular protein leakage in the rat parotid gland elicited by reflex stimulation, parasympathetic nerve stimulation and administration of neuropeptides. Regul. Pept. 77:1998;113-120.
22. Koyama S., Fujita T., Shibamoto T., Matsuda Y., Uematsu H., Jones R.O. Contribution of baroreceptor reflexes to blood pressure and sympathetic responses to cholecystokinin and vasoactive intestinal peptide in anesthetized dogs. Eur. J. Pharmacol. 175:1990;245-251.
23. Kirally A., Suto G., Guth P., Tache Y. Influence of [4Cl-D-Phe6,Leu17]VIP on VIP- and central TRH-induced gastric hyperemia. Peptides. 18:1997;1321-1325.
24. Broner C.W., O'Dorisio M.S., Rosenberg R.B., O'Dorisio T.M. Cyclic nucleotides and vasoactive intestinal peptide production in a rabbit model of Escherichia coli septicemia. Am. J. Med. Sci. 309:1995;267-277.
25. Bond R.F. Peripheral vascular adrenergic depression during hypotension induced by E. coli endotoxin. Adv. Shock. Res. 9:1983;157-169.
26. Lindblom L, Cassuto J, Yregård L, Räntfors J, Tarnow P, Löwhagen Hendén P. Importance of vasoactive intestinal polypeptide in the regulation of burn perfusion. Burns 2000;26:435-42.
27. Jakobsson O.P., Arturson G. The effect of prompt local cooling on oedema formation in scalded rat paws. Burns Incl. Thermal. Inj. 12:1985;8-15.
28. Marciniak D.L., Dobbins D.E., Maciejko J.J., Scott J.B., Haddy F.J., Grega G.J. Effects of systemically infused histamine on transvascular fluid and protein transfer. Am. J. Physiol. 233:1977;H148-H153.
29. Alessandrini F., Thakkar M., Foda H.D., Said S.I., Lodi R., Pakbaz H., Schraufnagel D.E. Vasoactive intestinal peptide enhances lung preservation. Transplantation. 56:1993;964-973.
30. Bellinger D.L., Lorton D., Brouxhon S., Felten S., Felten D.L. The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation. Adv. Neuroimmunol. 6:1996;5-27.
31. Gourlet P., Vertongen P., Vandermeers A., Vandermeers-Piret M.C., Rathe J., DeNeef P., Waelbroeck M., Robberecht P. The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass. Peptides. 18:1997;403-408.
32. Kalfin R., Maulik N., Engelman R.M., Cordis G.A., Milenov K., Kasakov L., Das D.K. Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium. J. Pharmacol. Exp. Ther. 268:1994;952-958.
33. Gurbuz V., Corak A., Yegen B.C., Kurtel H., Alican I. Oxidative organ damage in a rat model of thermal injury: the effect of cyclosporin A. Burns. 23:1997;37-42.
34. Williams T.J. Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin. Br. J. Pharmacol. 77:1982;505-509.
35. Schulze E., Witt M., Fink T., Hofer A., Funk R.H. Immunohistochemical detection of human skin nerve fibers. Acta Histochem. 99:1997;301-309.
36. Neely A.N., Imwalle A.R., Holder I.A. Recombinant neutral endopeptidase decreases oedema in the skin of burned guinea-pigs. Burns. 22:1996;520-523.
37. Friedl H.P., Till G.O., Trentz O., Ward P.A. Roles of histamine, complement and xanthine oxidase in thermal injury of skin. Am. J. Pathol. 135:1989;203-217.